Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cadonilimab Combined With Radical Radiotherapy in Locally Advanced Cervical Cancer
NCT07450963Phase 2Not yet recruiting
- Sponsor
- Ruijin Hospital
- Start
- Mar 2026
- Primary completion
- Feb 2029
- Modality
- Bispecific Antibodies
01
Overview
A Phase 2 trial of cadonilimab in Cervical Cancer (CC), sponsored by Ruijin Hospital. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
cadonilimab
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT07450963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07450963.